PFO - Patent Foramen Ovale Clinical Trial
Official title:
Amplatzer PFO Occluder Post-marketing Surveillance Study
The purpose of the Amplatzer PFO Occluder post-marketing clinical use surveillance study is to observe the frequency, type and degree of adverse device effects and adverse events in order to assure the safety of the new medical device, and to collect safety and efficacy information for evaluating the results of the clinical use.
Based on the Ministerial Ordinance on Good Post-marketing Study Practice for Medical Device, the Surveillance will register patients with patent foramen ovale (PFO) who have experienced a PFO-related cryptogenic cerebral infarction (including diagnosed paradoxical cerebral embolism) or transient ischemic attack (determined by positive head imaging such as DWI) in whom an Amplatzer PFO Occluder implant was attempted (Marketing Approval No. 30100BZX00024000, date May 28, 2019, hereinafter referred to as "PFO occluder"). ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04433520 -
Trevisio Post-Approval Study
|
||
Recruiting |
NCT05529901 -
Japan Post Marketing Surveillance of the GORE® CARDIOFORM Septal Occluder
|
||
Active, not recruiting |
NCT04029233 -
The PROOF Trial - Prospective, Open-label, Multicenter, Non-randomized Investigation on Percutaneous Patent Foramen Ovale (PFO) Closure Using the Occlutech PFO Occluder to Prevent Recurrence of Stroke in Patients With Cryptogenic Stroke and High Risk PFO
|
||
Recruiting |
NCT06046508 -
Migraine With Aura and Patent Foramen Ovale: Identification of Biomarkers to Select Patients In Whom Intervention Would Be Beneficial (MANET)
|
||
Recruiting |
NCT03821129 -
GORE® CARDIOFORM Septal Occluder and Antiplatelet Medical Management for Reduction of Recurrent Stroke in Patients With Patent Foramen Ovale (PFO): the REDUCE Post Approval Study
|
N/A | |
Not yet recruiting |
NCT06203873 -
A Comparison of Biodegradable and Metal Occluders in Patients With PFO and Migraine
|
N/A | |
Recruiting |
NCT06033937 -
COMPETE Cohort Study
|
||
Active, not recruiting |
NCT04100135 -
GORE® CARDIOFORM Septal Occluder Migraine Clinical Study
|
N/A | |
Recruiting |
NCT04946734 -
Effectivity and Safety of PFO Closure vs Medicine in Alleviating Migraine
|
Phase 3 |